The need for molecular diagnostic assays is growing at an unprecedented rate and the discovery of new biomarkers and improved accessibility to standard catalog reagents has allowed the creation of molecular tests faster than ever before.
Still, there are challenges to overcome. Standard catalog reagents can require cold-chain handling and storage, reaction components require multiple mixing steps and if reagents are not handled, stored or used properly, diagnostic tests could result in false positive or false negative results.
- Reduce expenses by eliminating the need for freezers and refrigerators
- Eliminate any mixing or handling steps at the point-of-use
- Increase the number of tests that can be run in clinical labs
